These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 3313522)

  • 1. [Anti-tumor factors in cartilage].
    Enomoto M; Takigawa M
    Tanpakushitsu Kakusan Koso; 1987 Jul; 32(8):1060-6. PubMed ID: 3313522
    [No Abstract]   [Full Text] [Related]  

  • 2. [Tumor necrotic factor as an inhibitor of angiogenesis].
    Sopotsinskaia EB; Lisniak IA
    Patol Fiziol Eksp Ter; 1988; (5):62-4. PubMed ID: 2464155
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of U-995, a potent shark cartilage-derived angiogenesis inhibitor, on anti-angiogenesis and anti-tumor activities.
    Sheu JR; Fu CC; Tsai ML; Chung WJ
    Anticancer Res; 1998; 18(6A):4435-41. PubMed ID: 9891506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cartilage-derived anti-tumor factor (CATF): partial purification and the mechanism of inhibitory action on tumor growth].
    Enomoto M
    Osaka Daigaku Shigaku Zasshi; 1987 Jun; 32(1):91-104. PubMed ID: 2462035
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of an inhibitor of neovascularization from cartilage.
    Moses MA; Sudhalter J; Langer R
    Science; 1990 Jun; 248(4961):1408-10. PubMed ID: 1694043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Isolation and characteristics of the neovascularization inhibitor from the vitreous body].
    Lisniak IA
    Vopr Med Khim; 1988; 34(2):16-8. PubMed ID: 3400186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recent progress in the development of anti-tumor metastatic drugs].
    Kumagai H
    Gan To Kagaku Ryoho; 1995 Apr; 22(5):585-91. PubMed ID: 7536403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenesis inhibitors link many diseases.
    Maugh TH
    Science; 1981 Jun; 212(4501):1374-5. PubMed ID: 7233226
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cloning, expression of soluble VEGFR2 fragment and its effect on tumor angiogenesis].
    Kou BJ; Li YL; Zhang LH; Zhu GB; Wang XR; Li YL; Wang YZ; Shi YA
    Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):337-41. PubMed ID: 15312342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effects of tumor invasion-inhibiting factor 2 and its conjugate on disseminating tumor cells.
    Isoai A; Goto-Tsukamoto H; Yamori T; Oh-hara T; Tsuruo T; Silletti S; Raz A; Watanabe H; Akedo H; Kumagai H
    Cancer Res; 1994 Mar; 54(5):1264-70. PubMed ID: 8118815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cartilage-derived factor. II. Purification and biological properties].
    Nomura Y
    J Osaka Univ Dent Sch; 1981 Jun; 26(1):137-47. PubMed ID: 6945422
    [No Abstract]   [Full Text] [Related]  

  • 12. [Angiogenesis--mechanisms and therapeutic approaches].
    Battegay E
    Praxis (Bern 1994); 1995 Feb; 84(5):118-21. PubMed ID: 7533322
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anti-angiogenesis, a possible new modality of cancer treatment].
    Fukushima M
    Gan To Kagaku Ryoho; 1983 Jul; 10(7):1591-7. PubMed ID: 6191687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of lymphocyte-induced angiogenesis by isolated chondrocytes.
    Kaminski M; Kaminska G; Jakobisiak M; Brezezinski W
    Nature; 1977 Jul; 268(5617):238-40. PubMed ID: 887155
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of tumor angiogenesis by non-steroidal anti-inflammatory drugs: emerging mechanisms and therapeutic perspectives.
    Dermond O; Rüegg C
    Drug Resist Updat; 2001 Oct; 4(5):314-21. PubMed ID: 11991685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Triggering factors and mechanisms of intratumorous angiogenesis].
    Zerbino DD; Dmitruk IM
    Vestn Akad Med Nauk SSSR; 1984; (5):44-8. PubMed ID: 6204466
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of new blood vessel formation in mice by systemic administration of human rib cartilage extract.
    Kamiński M; Kamińska G; Majewski S
    Experientia; 1978 Apr; 34(4):490-1. PubMed ID: 639947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [An experimental study of anti-angiogenesis with a cartilage-derived inhibitor].
    Gao X; Lou Y; Xi S; Feng W
    Zhonghua Yan Ke Za Zhi; 1999 Jan; 35(1):22-4, 2. PubMed ID: 11835768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibition of tumor angiogenesis as a cancer treatment].
    Verheul HM; Bom JB; Hoekman K; Pinedo HM
    Ned Tijdschr Geneeskd; 1999 Jul; 143(30):1549-55. PubMed ID: 10443279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombospondin-1 type 1 repeat recombinant proteins inhibit tumor growth through transforming growth factor-beta-dependent and -independent mechanisms.
    Miao WM; Seng WL; Duquette M; Lawler P; Laus C; Lawler J
    Cancer Res; 2001 Nov; 61(21):7830-9. PubMed ID: 11691800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.